Did you miss out on any of the excellence scientific presentations at SIR 2024? No need to worry. Below, find deep dives into the science and research that won Abstract of the Year and Featured Abstract designation.
-
1
Cryoablation for breast cancer safe and effective for nonsurgical candidates
Breast cancer patients who are unable or unwilling to undergo surgery may find a safe and viable treatment in cryoablation, according to data from a new, single-institution review.
-
2
Hemorrhoid artery embolization proves durable, effective for internal hemorrhoids
A new study shows that hemorrhoidal artery embolization is an effective, long-term outpatient treatment option for refractory symptomatic internal hemorrhoids.
-
3
chanawit - stock.adobe.com
New study identifies factors for higher intrahepatic cholangiocarcinoma survival rates
A new, 20-year population study of patients who received radiofrequency ablation for intrahepatic cholangiocarcinoma (iCCA) indicates that systemic therapy, local treatment and tumor size are associated with higher survival outcomes.
-
4
New model provides more accurate microwave ablation guidance
A new study reports the creation of an ex vivo human liver model for microwave ablation (MWA) research with the ability to produce the heat sink effect, which may advance guidance for clinical application, researchers say.
-
5
Histoplasty improves cancer treatment in mouse model
Researchers at the University of Wisconsin–Madison have developed a novel focused ultrasound procedure that successfully treated tumors, increased chemotherapy uptake and altered the tumor immune microenvironment in a mouse model of breast cancer.
-
6
Study suggests Y-90 could be delivered safely via bronchial artery to protect the lungs
Boston IRs collaborated with medical physicists to show that yttrium-90 (Y-90) radioembolization could be delivered via the bronchial artery for patients with inoperable primary lung cancer or cancer that has spread into the lungs.
-
7
Microwave ablation offers safe treatment option for early lung cancer
A new study shows that one type of IGTA—microwave ablation (MWA)—appears to be a safe, effective and non-inferior option when compared to either resection or SBRT as a primary therapy for early NSCLC.
-
8
New gallstone extraction technique provides safe alternative for non-surgical patients
A new IR procedure is safe and effective for patients with calculous cholecystitis—gallbladder infection caused by gallstones—who are poor surgical candidates.
-
9
TARE an option for hepatocellular carcinoma patients with hyperbilirubinemia
Yttrium-90 transarterial radioembolization (TARE) is a safe option for patients with hepatocellular carcinoma (HCC) and baseline hyperbilirubinemia, allowing for bridging or downstaging patients to liver transplant, a new retrospective study shows.
-
10
Percutaneous embolization offers safe alternative to TIPS in emergency cases
A retrospective study showed that the less common IR procedure percutaneous transhepatic variceal embolization (PTVE) was effective in emergent cases that were contraindicated for TIPS.
-
11
Voxel-based dosimetry offers more personalized approach for liver cancer treatment
A University of California San Diego (UCSD) research team showed that voxel-based dosimetry could accurately predict tumor pathology response in patients with hepatocellular carcinoma (HCC) undergoing yttrium-90 radioembolization.
-
12
New investigational Eye90 microspheres® radioembolization therapy treats liver cancer in a first-in-human pilot trial
A new imageable glass yttrium-90 (Y-90) radioembolization therapy has shown early safety and effectiveness in a first-in-human study for treating patients with unresectable hepatocellular carcinoma (HCC).
-
13
High pulmonary artery pressure doesn’t immediately disqualify PH patients from mechanical thrombectomy
Patients with severe pulmonary hypertension may experience safe, durable results after receiving mechanical thrombectomy (MT) for pulmonary embolism, according to recent data.
-
14
Thermal ablation with NK-cell based immunotherapy may improve HCC outcomes
While thermal ablation currently provides excellent outcomes for early-stage hepatocellular carcinoma (HCC), a new study indicates that applying nonlethal hyperthermia may also improve natural killer (NK) cell cytotoxicity and effect better outcomes
-
15
Postprocedural hemoglobin may be affected by use of autotransfusion device during large-bore aspiration thrombectomy
A recent study has compared postprocedural changes in hemoglobin following catheter-directed thrombolysis (CDL) versus large-bore aspiration thrombectomy (LBAT) of acute pulmonary embolism (PE).
-
16
Ultrasound microbubble destruction effective with radioembolization for HCC
Updated data indicate that ultrasound-triggered microbubble destruction (UTMD) may play an effective role in improving outcomes for hepatocellular carcinoma (HCC) when paired with Y-90 radioembolization.
-
17
PEF shows more favorable response than IRE in ablation comparison study
A recent study comparing ablation technologies on murine cancer models indicates promising results for advanced biphasic PEF ablation and may have achieved an improved post-ablation environment to induce the abscopal effect, according to researchers.
-
18
Interim data available from world’s largest study on TARE for HCC
Early data from the world’s largest prospective registry study on TARE with Y-90 glass microspheres in the treatment of primary and metastatic liver tumors demonstrate prolonged survival and a low adverse event rate, and therefore a positive benefit.
